A novel radiotracer alone can detect nearly 30 types of cancer, which was chosen as the image of the year at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). It is expected to pave the way for the development of new therapies of cancer. SNMMI chooses an image which shows the most promising advances in nuclear medicine and molecular imaging every year. The positron emission tomography/computed tomography (PET/CT) with a fibroblast-activation protein inhibitor (FAPI) shows exceptionally clear tumor images by using 68Ga-FAPI as a radiotracer.
To read more please visit:
http://www.snmmi.org/NewsPublications/NewsDetail.aspx?ItemNumber=32020
Source: SNMMI